A raised HbA1c result at an executive health assessment deserves a clear medical explanation and a plan. It can identify a higher risk of type 2 diabetes or a result that needs confirmation for a possible diagnosis. Your doctor should also consider whether the test is reliable for you, how the result fits your history and what needs to happen next. A highlighted number is the start of that discussion, not the whole conclusion.
The Wellness offers doctor-led blood testing and results review in London. The aim is to connect the result with practical care: the right confirmation when needed, support for changes that fit your life and a defined follow-up. When you already have diabetes, the conversation is different again, because your treatment target is personal rather than simply the laboratory's normal range.
Arrange a doctor-led review of your HbA1c with The Wellness
What HbA1c measures
HbA1c is sometimes called glycated haemoglobin. Glucose attaches to haemoglobin within red blood cells, and the test measures the proportion affected. It reflects blood glucose over roughly the previous three months, with the more recent period contributing more strongly. It is therefore different from a glucose measurement taken at a single moment.
That longer view is useful when the clinical question concerns persistent raised glucose rather than one meal or one morning's result. It also explains why the test is not an immediate score for yesterday's food. A careful review can distinguish a meaningful trend from the expectation that a short burst of dietary change should transform a result straight away.
The NIDDK explanation of the A1c test sets out its uses and limitations. In the UK, results are commonly reported in mmol/mol. Some overseas reports use percentages. Keeping the original report and its units helps the doctor interpret previous results accurately, particularly if your medical records span several countries.
Understanding a result of 42 to 47 mmol/mol
NICE guidance on preventing type 2 diabetes identifies HbA1c of 42 to 47 mmol/mol as indicating high risk in the relevant risk-assessment pathway. This range is often described as non-diabetic hyperglycaemia or prediabetes. It is not the same as a confirmed diagnosis of type 2 diabetes, and progression is not inevitable.
The result is useful because it gives an opportunity to address risk while keeping the discussion proportionate. The doctor can consider weight history, activity, family history, medicines and other health conditions. The plan should explain what the result means for you rather than turn a population threshold into a prediction that a particular outcome will definitely occur.
NICE recommends evidence-based lifestyle support for people confirmed to be at high risk and a blood test at least annually in that pathway. The individual plan can differ when there are symptoms, a rapid change, uncertainty about the measurement or another clinical reason for earlier review. An annual screening interval is not an instruction to wait when something new needs assessment.
What happens at 48 mmol/mol or above
An HbA1c of 48 mmol/mol or above is a possible diabetes result in the appropriate diagnostic setting. For someone without symptoms, NICE recommends a second blood test to confirm the diagnosis. That confirmation protects the quality of the decision and helps the clinician assess whether the measurement matches the clinical picture.
A repeat is not a reason to dismiss the first result. The doctor should explain the next test, when it should happen and how you will receive the conclusion. The need for confirmation also should not be interpreted as a fixed waiting period for everyone. Symptoms, the degree of abnormality and your overall condition can change the urgency and the tests required.
If diabetes is confirmed, care moves beyond the screening report. You need an explanation of the diagnosis, an agreed treatment and monitoring plan, and consideration of related cardiovascular, kidney and other health needs. The appropriate arrangements depend on your situation. A private screening visit should connect you with continuing care, not leave you to interpret a diagnosis alone.
When symptoms matter more than a screening label
The NHS describes common diabetes symptoms including increased thirst, passing urine more often, tiredness and unexplained weight loss. Blurred vision, recurrent thrush or infections and wounds that heal slowly can also be relevant. These symptoms have more than one possible cause, which is why clinical assessment matters.
A person with new symptoms needs an appropriate assessment even if an earlier HbA1c was reassuring. HbA1c is not the right standalone test for every situation, including suspected rapidly developing diabetes. It should not be used to reassure someone out of seeking help when their current condition suggests a more urgent problem.
If you are becoming seriously unwell, especially with vomiting, marked dehydration, unusual drowsiness or breathing difficulty, seek urgent medical help rather than wait for an executive-screening appointment. The immediate priority is assessment of the illness. Once that is addressed, longer-term metabolic care can be organised around the diagnosis and the treatment you need.
Why HbA1c and glucose can disagree
A fasting glucose result is a snapshot after the required fasting period. HbA1c reflects a longer interval. They can therefore provide different information, and a disagreement does not automatically mean that one laboratory has made a mistake. The doctor considers the pattern, the reason for testing and whether confirmation with another method is appropriate.
NIDDK notes that different tests may identify different people as having diabetes or increased risk. A result close to a threshold also needs a measured discussion of variation and repeat testing. A small numerical movement should not be treated as a complete change in your health without considering the surrounding evidence.
The aim is to select a test that answers the clinical question. For some people, that will be another HbA1c. In other circumstances, a plasma glucose test or a different assessment is more useful. The clinician should explain the choice and interpret the result, rather than adding an expanding list of biomarkers without a clear decision attached.
Discuss a raised screening result with The Wellness
When the HbA1c measurement needs extra care
HbA1c depends on red blood cells as well as glucose. Conditions that affect haemoglobin or red-cell survival can change its reliability. NICE specifically highlights haemoglobin variants and haemolysis. In those circumstances, glucose-based testing may be needed for diagnosis rather than relying on HbA1c in the usual way.
NIDDK also describes possible interference from iron deficiency, blood loss, transfusion and other health conditions. This does not mean that every mildly unusual blood count makes the result unusable. It means that the medical history and the rest of the report can matter to the interpretation, especially when the number does not fit your symptoms or previous results.
Tell the reviewing doctor about recent transfusion, significant bleeding, known anaemia, haemoglobin conditions and kidney treatment. Pregnancy and possible rapidly developing diabetes require their own clinical pathways. The value of medical review is recognising when a familiar test needs a different approach, rather than applying the same threshold to every person in every setting.
Fasting, medicines and preparing for the appointment
HbA1c itself does not require fasting. A broader panel can include tests that do, such as a fasting glucose measurement. Follow the instructions for the tests actually booked rather than assume that every blood test has the same preparation. The team can confirm the arrangements before your appointment.
Bring or send a current list of prescribed medicines and supplements. Some treatments can affect glucose, while changes in other health conditions may alter how the result is interpreted. Do not stop prescribed medication to improve a screening result or change a diabetes medicine without advice from the clinician responsible for your care.
Previous reports are often useful. Include the original result, the date, the units and any relevant notes about treatment at the time. A sequence of results can show whether the present number is new, stable or changing. It also helps avoid unnecessary duplication when recent testing already answers part of the question.
A metabolic plan that fits a demanding schedule
Where increased risk is confirmed, the next step should be more useful than a generic instruction to be healthier. NICE recommends structured, evidence-based support. The discussion can focus on eating patterns, physical activity, reducing sedentary time and weight management where appropriate, with attention to what you can sustain during work and travel.
The plan should recognise your starting point. A person who travels most weeks may need different practical arrangements from someone with a regular routine. Your doctor can help establish the medical priorities and arrange suitable support. The aim is consistent progress and follow-up, not a restrictive short-term programme designed only to produce a better-looking report.
A lower future result can be encouraging, but the interpretation remains clinical. Diabetes risk is influenced by more than a single measurement, and some people need treatment despite careful changes to their habits. A useful service makes it easier to understand the next decision without making you responsible for managing every uncertainty yourself.
Looking beyond glucose without ordering everything
HbA1c often appears beside cholesterol, kidney function and other results in an executive assessment. These findings should be read together when they contribute to care. Blood pressure, smoking, family history and established conditions may also influence the overall risk discussion. The number of tests is less important than the relevance of the information.
A normal HbA1c is not a complete cardiovascular clearance. Equally, a raised HbA1c does not explain every symptom or every abnormal test. The doctor can separate related findings from issues that need their own evaluation. That keeps the plan focused and avoids assuming that one metabolic label accounts for everything in the report.
The Wellness blood-testing service describes doctor-reviewed results and follow-up planning. The appropriate panel and review should be agreed for your circumstances. Additional investigations or specialist consultations, if recommended, need a clear purpose and confirmation of their arrangements before they are booked.
If you already have diabetes
For someone with established diabetes, HbA1c is used to assess longer-term glucose management. Diagnostic thresholds for someone who has never been diagnosed are not a personal treatment target. Targets depend on factors including your treatment, other health conditions and the risk of hypoglycaemia, which is low blood glucose.
NIDDK stresses that an HbA1c goal that is suitable for one person may not be safe for another. An unexpectedly low result is not automatically a reason to intensify care or celebrate tighter control if it comes with frequent low-glucose episodes. Your symptoms and day-to-day glucose information may change the interpretation.
Bring your existing diabetes plan to the review. Any proposed change should take account of the care you already receive and be communicated with the relevant clinicians with your consent. An executive assessment can help organise the picture, but it should not create disconnected advice that leaves you choosing between conflicting treatment instructions.
A clear handover after the result
A useful review ends with the meaning of the result, the next action and responsibility for that action. If a confirmation test is needed, the plan should say how it will be arranged and who will explain it. If prevention support is recommended, there should be a practical route to that support rather than an unresolved suggestion.
For people travelling after the assessment, arrangements for results and follow-up are especially important. A written summary helps the next clinician understand what was measured, what remains uncertain and what has already been agreed. With your consent, relevant information can be shared so that the follow-up starts from the same clinical picture.
The fee, scope of the review and any additional tests should be confirmed before booking. The value is a medical interpretation and a workable next step. It is not a guarantee that screening will prevent diabetes or identify every condition. The Wellness can help you move from an isolated result to an organised plan for your care.
Request an HbA1c and biomarker results review in London
Frequently asked questions
What does HbA1c of 42 to 47 mmol/mol mean?
In the relevant UK risk-assessment pathway, this range indicates a higher risk of type 2 diabetes and is often called prediabetes or non-diabetic hyperglycaemia. It does not mean progression is inevitable. A doctor can interpret the result with your history and agree prevention support and follow-up.
Does HbA1c of 48 mmol/mol mean I definitely have diabetes?
It is a possible diabetes result in the appropriate clinical setting. NICE recommends a second blood test for people without symptoms to confirm the diagnosis. Symptoms, rapidly developing illness and factors affecting HbA1c reliability can require a different assessment and urgency.
Do I need to fast for an HbA1c blood test?
HbA1c itself does not require fasting. Other tests in the same appointment may have different instructions. Follow the preparation confirmed for your particular panel and do not stop prescribed medication without medical advice.
Can anaemia affect an HbA1c result?
Some conditions affecting haemoglobin or red-cell survival can alter HbA1c reliability. Iron deficiency, significant blood loss and transfusion can also matter. Tell the reviewing doctor about these factors so they can decide whether another test is more appropriate.
How often should a raised HbA1c be checked?
Timing depends on whether the purpose is diagnostic confirmation, prevention follow-up or monitoring established diabetes. NICE recommends at least annual blood testing in its high-risk prevention pathway, but symptoms or other concerns can justify earlier assessment. Follow an individual medical plan.
Can The Wellness review a result from another clinic?
You can request a doctor-led review and provide the original report, including its date and units, together with your medical and medication history. The team confirms the scope and fee before booking. Further tests may be recommended if the existing information does not settle the clinical question.
This article provides general information, not a diagnosis or an individual treatment plan. New or worsening symptoms need appropriate medical assessment even when a previous screening test was within range.
Contact The Wellness about your blood test results
Sources
- NICE PH38, type 2 diabetes prevention, UK risk thresholds, confirmation and prevention follow-up.
- NIDDK, the A1c test and diabetes, measurement, preparation, limitations and individual treatment targets.
- NHS, type 2 diabetes symptoms and diagnosis, symptoms and clinical assessment.
- The Wellness, blood tests, service and doctor-led interpretation.